Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Tongue Neoplasms 1 Thyroid Neoplasms 1 Thymus Neoplasms 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Skin Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Kaposi 1 Sarcoma 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pheochromocytoma 1 Pharyngeal Neoplasms 1 Penile Neoplasms 1 Pathologic Complete Response 1 Parotid Neoplasms 1 Parathyroid Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1

Interventions

Fulvestrant 3 palbociclib 2 Letrozole 2 Anastrozole 2 venetoclax 1 pyrotinib 1 pertuzumab 1 penpulimab 1 dalpiciclib 1 anlotinib 1 Tretinoin 1 Trastuzumab 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Ondansetron 1 Morphine 1 Induction Chemotherapy 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasm Female × Patient Reported Outcome Measures × Breast × Clear all

NCT06080607 2024-03-25

PRO

Regina Elena Cancer Institute

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡